Abiraterone acetate, Olaparib, and Prednisolone
About
Membership operator: AND
Therapies: 3
Therapies
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy group.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (2) | BRCA1 oncogenic variants | Prostate Adenocarcinoma | Abiraterone acetate, Olaparib, Prednisolone | |
| FDA (2) | BRCA1 pathogenic variants | Prostate Adenocarcinoma | Abiraterone acetate, Olaparib, Prednisolone | |
| FDA (2) | BRCA2 oncogenic variants | Prostate Adenocarcinoma | Abiraterone acetate, Olaparib, Prednisolone | |
| FDA (2) | BRCA2 pathogenic variants | Prostate Adenocarcinoma | Abiraterone acetate, Olaparib, Prednisolone |